
	Where results make sense

Topic: Enzyme inhibitor

Related Topics

restriction enzymes

liver enzymes

rate of enzyme mediated reactions

angiotensin converting enzyme inhibitors

enzyme kinetics

enzyme catalysis

metabolic enzyme

Enzyme Linked Immunosorbent Assay

hydrolytic enzyme

Cardiac enzymes

degradative enzyme

enzyme allostery

In the News (Mon 6 Oct 08)

Eli Manning

Josh Beckett

Sage Rosenfels

South Ossetia

Super League

Angelina Jolie

West Bengal

Wayne Rooney

Howard Stern

Beth Ostrosky

	Enzyme - Wikipedia, the free encyclopedia
		Enzymes are usually specific as to the reactions they catalyze and the substrates that are involved in these reactions.
		Enzymes are very specific and it was suggested by Emil Fischer in 1890 that this was because the enzyme had a particular shape into which the substrate(s) fit exactly.
		By changing the conformation (the three-dimensional structure) of the enzyme, they disable or enable the ability of the enzyme to turn over its substrate, while substrate binding is still possible (in other words: there is no competition between substrate and inhibitor for the enzyme).
	en.wikipedia.org /wiki/Enzyme (3430 words)

	Enzymes, Kinetics and Diagnostic Use
		Plasma membrane enzymes regulate catalysis within cells in response to extracellular signals, and enzymes of the circulatory system are responsible for regulating the clotting of blood.
		As enzymes have a more or less broad range of substrate specificity, it follows that a given substrate may be acted on by a number of different enzymes, each of which uses the same substrate(s) and produces the same product(s).
		The kinetic effect of irreversible inhibitors is to decrease the concentration of active enzyme, thus decreasing the maximum possible concentration of ES complex.
	web.indstate.edu /thcme/mwking/enzyme-kinetics.html (5727 words)

	[No title]
		The noncompetitive inhibitor, Inc, forms a complex with enzyme, which is unaffected by the substrate concentration, such that it does not matter if substrate is already bound to the enzyme when the noncompetitive inhibitor binds or not.
		The inhibitors of both types are used at known concentrations ([I]) and these must be used to find the strength of the binding of the inhibitor to the enzyme (Ki) and the Ki has the same units of concentration as does the inhibitor.
		So the degree to which the inhibitor effects the kinetics of the enzyme depends on both the strength of its complex with the enzyme, with a low Ki indicating strong binding of the inhibitor to the enzyme, and the concentration of the inhibitor added to the kinetic analysis.
	www.bio.mtu.edu /campbell/482kin1.html (1565 words)

	Botany online: Physical Chemistry - Enzyme Catalysis - Inhibition (Site not responding. Last check: 2007-11-04)
		The enzyme molecules are thus to a large degree inactivated by the binding of the inhibitor.
		Reduction of the turn-over ratio of an enzyme-catalyzed reaction by a non-competitive inhibitor.
		That shows that all enzyme molecules in the solution are fully active at the beginning of the reaction and that they display increased turn-over ratios (compared to values obtained at lower temperatures).
	www.biologie.uni-hamburg.de /b-online/e18/18e.htm (667 words)

	Enzyme kinetics in the presence of an inhibitor
		Enzyme kinetics in the presence of an inhibitor
		One way to measure the effect of an inhibitor is to measure enzyme velocity at a variety of substrate concentrations in the presence and absence of an inhibitor.
		Another experimental design is to measure enzyme velocity at a single concentration of substrate with varying concentrations of a competitive inhibitor.
	www.graphpad.com /curvefit/inhibitors.htm (647 words)

	UCLA Department of Medicine - wfsection-Angiotensin-Converting Enzyme Inhibitor Induced Cough Among Asians
		Angiotensin-converting enzyme (ACE) inhibitors have added a new dimension to the treatment of hypertension, congestive heart failure and post myocardial infarction, and are now playing an important role in the treatment of endothelial dysfunction.
		The literature is replete with articles concerning cough induced by ACE inhibitors and the incidence of the cough ranges from 3.7% to as high as 33%.
		Although the number of patients was small, the incidence of ACE inhibitor induced cough was estimated to be at about 45% among the Asian women with approximately 15% of the patients ceasing treatment.
	www.med.ucla.edu /modules/wfsection/article.php?articleid=135 (2094 words)

	Enzyme Inhibitor Reduces Lung Inflammation Caused by Tobacco Smoke - DERT
		This enzyme is concentrated in the smooth muscle tissue of the veins and arteries that carry blood between the heart and lungs.
		The rats were exposed to tobacco smoke; some were given the sEH inhibitor and others were given the inhibitor along with EET implants.
		Rats that were injected with the inhibitor along with receiving the EET implant had even less inflammation.
	www.niehs.nih.gov /dert/profiles/hilites/2005/sEH.htm (382 words)

	Enzyme Inhibition (Site not responding. Last check: 2007-11-04)
		Inhibitor is usually structurally very similar to the substrate.
		If acetlycholine cannot be hydrolyzed by this enzyme, nerve signals cannot be passed across the synapses of the nervous system.
		In fact, the cooperativity observed in allosteric enzymes is analyzed using the Hill equation and Hill plots to obtain values for K
	www.nitorig.net /lec15.html (962 words)

	ACE inhibitor on Encyclopedia.com (Site not responding. Last check: 2007-11-04)
		(āand180;sēand180;ē´, ās) or angiotensin-converting enzyme inhibitor, drug used to reduce elevated blood pressure (see hypertension), to treat congestive heart failure, and to alleviate strain on hearts damaged as a result of a heart attack (see infarction).
		ACE inhibitors block production of an enzyme that helps convert the protein angiotensin 1 into angiotensin 2, a protein that makes blood vessels constrict and promotes retention of fluid, raising blood pressure.
		Thus ACE inhibitors act to widen the blood vessels and make it easier for the heart to pump blood through the body.
	www.encyclopedia.com /html/A/AC1E1-i.asp (485 words)

	Angiotensin-Converting Enzyme Inhibitor Associated Angioedema of the Intestine: A Case Report and Review of the ... (Site not responding. Last check: 2007-11-04)
		Angiotensin converting enzyme inhibitors (ACEI) are being used with increasing frequency for treatment of hypertension, congestive heart failure and diabetic nephropathy.
		The patient was treated with intravenous hydration, avoidance of ACE inhibitors and initiation of histamine H1 and H2 receptor blocker therapy.
		Angiotensin converting enzyme inhibitor induced angioedema of the intestine (AIAI) is a rare complication of ACEI therapy.
	www.acofp.org /member_publications/0205_2.htm (3193 words)

	enzymes_1
		Upon completion of the lecture students will know concepts associated with drugs that target enzymes, including irreversible enzyme inhibitors, with particular emphasis on the antihypertensive drugs that inhibit the enzyme, angiotensin converting enzyme.
		Enzyme catalysis occurs due to a lowering of the energy of the transition state, therefore,
		active-site directed reagent (unreactive) which binds to the enzyme active site where it is transformed to a reactive form (activated) by the enzyme's catalytic capabilities.
	www.pharmacy.umaryland.edu /courses/PHAR531/lectures_old/enzymes_1.html (1392 words)

	Asymmetric mutation rates at enzyme-inhibitor interfaces: Implications for the protein-protein docking problem -- ...
		This ratio is determined by dividing the percentage of conserved (or variable) surface vertices within the interface by the corresponding percentage in the noninteracting surface.
		Beuning, L.L., Spriggs, T.W., and Christeller, J.T. Evolution of the proteinase inhibitor I family and apparent lack of hypervariability in the proteinase contact group.
		Hill, R.E. and Hastie, N.D. Accelerated evolution in the reactive centre regions of serine protease inhibitors.
	www.proteinscience.org /cgi/content/full/12/9/2099 (2927 words)

	Binding Studies of Glycosidase Inhibitors with Basic Nitrogen Instead of Oxygen in the Sugar Ring: Modeling of ...
		The pictures are from a MD run of 20,000 ps at 300 K. The view is from outside the enzyme, the inhibitor is slowly moving toward the viewer.
		In this attempt to draw conclusions from the data obtained by fitting a range of good as well as poor inhibitors into the acive site of glucoamylase emphasis was layed upon the hydrogen bonding interactions between the enzyme and the respective inhibitor.
		Although this approach disregards the relative basicites of the ring nitrogens interesting correlations between the biological activities and the number of hydrogen bonds in the enzyme inhibitor complexes have been detected.
	www.ch.ic.ac.uk /ectoc/echet96/papers/050 (1182 words)

	Enzyme definition - Medical Dictionary definitions of popular medical terms
		Enzyme: A protein (or protein-based molecule) that speeds up a chemical reaction in a living organism.
		In 1902 Sir Archibald Garrod was the first to attribute a disease to an enzyme defect, to what Garrod called an "inborn error of metabolism." Today, newborns are routinely screened for certain enzyme defects such as PKU (phenylketonuria) and galactosemia, an error in the handling (metabolism) of the sugar galactose.
		Cox-2 Inhibitors - Explanation of Cox-2 Inhibitors and Cox-2 inhibitor drugs used to treat the pain and swelling of arthritis inflammation.
	www.medterms.com /script/main/art.asp?articlekey=3266 (344 words)

	BioMed Central \| Full text \| Angiotensin converting enzyme inhibitor therapy in children with Alport syndrome: effect ...
		Angiotensin converting enzyme inhibitors are routinely prescribed to patients with chronic kidney disease because of their known renoprotective effects.
		We evaluated the effect of short-term therapy with the angiotensin converting enzyme inhibitor, enalapril, in early Alport syndrome, defined as disease duration less than 10 years and a normal glomerular filtration rate.
		Treatment with angiotensin converting enzyme inhibitors (ACEI) is renoprotective in virtually all proteinuric forms of kidney disease [6].
	www.biomedcentral.com /1471-2369/3/2 (2907 words)

	NEJM -- Effect of the Angiotensin-Converting-Enzyme Inhibitor Benazepril on the Progression of Chronic Renal ...
		Giatras, I., Lau, J., Levey, A. Effect of Angiotensin-Converting Enzyme Inhibitors on the Progression of Nondiabetic Renal Disease: A Meta-Analysis of Randomized Trials.
		Schoolwerth, A. C., Sica, D. A., Ballermann, B. J., Wilcox, C. Renal Considerations in Angiotensin Converting Enzyme Inhibitor Therapy: A Statement for Healthcare Professionals From the Council on the Kidney in Cardiovascular Disease and the Council for High Blood Pressure Research of the American Heart Association.
		Angiotensin converting enzyme inhibitors and angiotensin receptor (AT1) antagonists: either or both for primary renal disease.
	content.nejm.org /cgi/content/abstract/334/15/939 (3643 words)

	Hypertension Online Slides - REIN, angiotensin converting enzyme inhibitor
		In the Angiotensin-Converting Enzyme Inhibition in Progressive Renal Insufficiency Study (AIPRI), the risk of doubling the serum creatinine concentration in these 583 nondiabetic patients was lowered by using benazepril to achieve better blood pressure control as compared with using conventional antihypertensive therapy.
		In the Angiotensin-Converting Enzyme Inhibition in Progressive Renal Insufficiency Study (AIPRI) the risk of doubling the serum creatinine concentration in these 583 patients was lowered by using benazepril to achieve better blood pressure control as compared with using conventional antihypertensive therapy.
		The Ramipril Efficacy In Nephropathy (REIN) study is the second clinical trial to confirm that ACE inhibitors have a similar action in patients with chronic non-diabetic nephropathies.
	www.hypertensiononline.org /slides2/slide01.cfm?q=REIN (867 words)

	angiotensin-converting enzyme inhibitor on Encyclopedia.com (Site not responding. Last check: 2007-11-04)
		Airway compromise due to angiotensin-converting enzyme inhibitor-induced angioedema *: clinical experience at a large community teaching hospital.(clinical investigations)(treatment of vascular disease...
		COX inhibitors counter the effects of ACE inhibitors, elevate BP.(From the literature)(cyclooxygenase)(angiotensin-converting enzyme)(blood pressure)
		Angiotensin-Converting Enzyme Inhibitors, Angiotensin II Receptor Antagonists, and Symptomless Dysphagia.
	www.encyclopedia.com /html/X/X-angtnsncnv.asp (281 words)

	DynaFit - (Bio)Chemical Kinetics and Equilibria
		The experimental data can be either initial reaction velocities in dependence on the concentration of varied species (e.g., inhibitor concentration vs. velocity), or the reaction progress curves (e.g., time vs. absorbance).
		A computer program with the code name DYNAFIT was developed for fitting either the initial velocities, or the time-course of enzyme reactions, to an arbitrary molecular mechanism represented symbolically by a set of chemical equations.
		Three different sets of progress curves were analyzed (i) to determine the kinetic properties of an irreversible inhibitor; (ii) to investigate the dissociation and denaturation mechanism for the protease dimer; and (iii) to investigate the inhibition mechanism for a transient inhibitor.
	www.biokin.com /dynafit (427 words)

	Contact info:
		We are developing a microfluidic device for a microdroplet enzyme-inhibitor assay.
		Alternating microdrops of a buffer solution containing enzyme and inhibitor reagents and perfluorodecalin (PFD) are formed in a continuous flow of hexadecane.
		A substrate solution is then introduced into the reagent microdrops after homogeneous mixing of the enzyme and the inhibitor.
	deas.harvard.edu /projects/weitzlab/research/Microfluidics/kahnez01.htm (141 words)

	ASN: Angiotensin Receptor Blocker Plus Angiotensin Converting Enzyme Inhibitor Enhances Angiotensin II Blocking Effect (Site not responding. Last check: 2007-11-04)
		Compared with the ACE inhibitor alone, the ACE inhibitor plus the ARB lowered urinary protein excretion in each patient independent of baseline protein excretion or renal diagnosis.
		In nine subjects, aldosterone was acutely lowered (p<.009), suggesting that angiotensin II levels were incompletely blocked by the ACE inhibitor.
		Panos attributed the additive effects of the ARB, at least in part, to greater inhibition of angiotensin II in the renal tissues and adrenal glomerulosa.
	www.docguide.com /dg.nsf/PrintPrint/F1C105B9B123ADC585256C6700574D18 (474 words)

	Clinical Trial: Effects of Angiotensin-Converting Enzyme Inhibitor (Ramipril) Therapy on Blood Vessel Inflammation
		Studies of patients with coronary artery disease suggest that ACE inhibitor therapy reduces the risk of heart attack and heart failure.
		That is, those who took ACE inhibitor for the first 3-month period will take placebo for the second 3-month period and vice versa.
		Angiotensin converting enzyme (ACE) inhibitor therapy reduces cardiovascular events in patients with coronary artery disease (CAD), potentially by reducing vascular oxidant stress and activation of genes that encode protein mediators of inflammation.
	clinicaltrials.gov /show/NCT00005928 (783 words)

	angiotensin-converting enzyme inhibitor
		Heart failure mortality among older medicare beneficiaries: association with left ventricular function evaluation and angiotensin-converting enzyme inhibitor use.
		The effects of preoperative therapy with angiotensin-converting enzyme inhibitors on clinical outcome after cardiovascular surgery.
		Age-related underutilization of angiotensin-converting enzyme inhibitors in older hospitalized heart failure patients.
	www.infoplease.com /ce6/sci/A0910277.html (152 words)

	AllRefer.com - angiotensin-converting enzyme inhibitor (Pharmacology) - Encyclopedia
		AllRefer.com - angiotensin-converting enzyme inhibitor (Pharmacology) - Encyclopedia
		You are here : AllRefer.com > Reference > Encyclopedia > Pharmacology > angiotensin-converting enzyme inhibitor
		More articles from AllRefer Reference on angiotensin-converting enzyme inhibitor
	reference.allrefer.com /encyclopedia/X/X-angtnsncnv.html (102 words)

	Asphyxia due to angiotensin converting enzyme (ACE) inhibitor mediated angioedema of the tongue during the treatment of ... (Site not responding. Last check: 2007-11-04)
		Asphyxia due to angiotensin converting enzyme (ACE) inhibitor mediated angioedema of the tongue during the treatment of hypertensive heart disease.
		Abstract: This report describes seven deaths caused by angioedema of the tongue related to angiotensin converting enzyme (ACE) inhibitors.
		The cases involved African-American men and women, aged 51 to 65 years, all of whom had been prescribed an ACE inhibitor for the treatment of hypertensive heart disease.
	www.astm.org /jforensicsci/PAGES/3672.htm (194 words)

	Clinical Trial: Prevention of Events with Angiotensin-Converting Enzyme Inhibitor Therapy (PEACE)
		To determine whether the addition of angiotensin converting enzyme (ACE) inhibitor to standard therapy in patients with known coronary artery disease and preserved left ventricular function will prevent cardiovascular mortality and reduce the risk of myocardial infarction.
		Prior studies with converting enzyme inhibitor (CEI) therapy in patients with depressed ejection fraction have demonstrated that their long-term administration leads to improved survival and reduced risk of myocardial infarction over and above conventional therapy.
		Patients are randomly assigned to treatment groups in which the addition of the angiotensin-converting enzyme (ACE) inhibitor trandolapril is compared to standard therapy.
	clinicaltrials.gov /show/NCT00000558 (523 words)

	CHBPR: Angiotensin Converting Enzyme Inhibitor-Induced Angioedema Associated With Low Enzyme Levels (Site not responding. Last check: 2007-11-04)
		CHICAGO, IL -- September 23, 2001 -- Patients who experience potentially life-threatening angioedema as a result of treatment with angiotensin converting enzyme inhibitors consistently have low levels of the enzyme dipeptidyl peptidase IV (DPP).
		The evidence was presented yesterday in a poster (September 22) at the meeting of the Council for High Blood Pressure Research, in Chicago, Illinois, United States, by Jean Lefebvre, MD, and his colleagues at Vanderbilt University in Nashville, Tennessee, and at Loyola University in Maywood, Illinois.
		The researchers found that every patient experiencing acute angiotensin converting enzyme (ACE) inhibitor-induced angioedema had serum DPP levels lower than the average levels seen in ACE inhibitor-treated patients without angioedema, in patients who had recovered from angioedema, in patients with angioedema due to other causes, and in other control groups.
	www.docguide.com /dg.nsf/PrintPrint/44CC8A38A25FA17485256AD000600737 (443 words)

	Angiotensin Converting Enzyme (ACE) Inhibitors, Cincinnati Children's Hospital Medical Center (Site not responding. Last check: 2007-11-04)
		ACE inhibitors cause dilation of the arterial system, not always associated with a lowering of the blood pressure.
		This vasodilation helps the heart function in many patients by decreasing how hard the ventricle has to squeeze to eject blood.
		ACE inhibitors are now the second most common class used in congestive heart failure in children.
	www.cincinnatichildrens.org /health/info/heart/medication/ace.htm (126 words)

Try your search on: Qwika (all wikis)